Aging and Disease

Brain blood flow rose in older adults reporting cognitive decline

Blood flow in one brain region rose by 4.9 milliliters per 100 grams per minute more with spermidine than placebo over 12 months.

Paper by Claudia Schwarz, Katharina Wurdack, Stefan Hetzer, +12 more authorsAgnes Flöel · Universitätsmedizin Greifswald
Brain sections show fuller blood flow and aligned nerve fibers in dark blue-green, beside sparser flow and less aligned fibers in gray.
Studied:
Randomized trial in 75 people (12 months, double-blind, placebo-controlled)
In the record:
The 70th paper on spermidine with results in people; 481 on record in all.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Researchers analyzed brain scans from 75 adults aged 60–90 with self-reported cognitive decline in a randomized trial. Participants took 0.9 milligrams of spermidine daily or a placebo for 12 months. Neither participants nor researchers knew who received which.

Blood flow rose more with spermidine in the precuneus, a brain region. In one bundle of nerve fibers, a scan measure used to assess fiber structure stayed stable with spermidine but fell with placebo. The researchers found no substantial group differences in brain volume, the thickness of the brain’s outer layer or bright spots in the brain’s nerve-fiber tissue on scans. The regional scan changes were not associated with changes in memory performance or participants’ cognitive complaints.

Why it matters

For older adults at risk of cognitive decline, the study addressed whether spermidine could affect aspects of brain health beyond memory performance.

Caveats

This was an exploratory secondary analysis of 75 participants. The findings are preliminary and require independent confirmation.

Comments

Be the first to comment.